HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paraneoplastic cerebellar ataxia associated with anti-Hu antibodies and benign ganglioneuroma.

Abstract
We describe a case of cerebellar ataxia associated with anti-Hu antibodies and benign ganglioneuroma. A 28-year-old woman developed progressive ataxia with hyporeflexia at the age of 19. Brain MRI showed progressive cerebellar atrophy. Neurophysiological studies, screening of immune-mediated ataxias, oncological markers, vitamin E and genetic tests for spinocerebellar ataxia types 1,2,3, Friedreich ataxia and POLG1 were negative. Anti-Hu antibodies were positive in Western blot and indirect immunofluorescence (1:640). Total-body computed tomography revealed a mediastinum mass; the histological diagnosis was maturing ganglioneuroma. Immunohistochemistry showed a mild reaction between the tumor and the patient's serum, and no reaction between the tumor and control serum. After surgery, serum anti-Hu titer decreased, while ataxic symptoms initially worsened and then stabilized. Ganglioneuroma is a benign tumor, usually derived from the maturation of a neuroblastoma. The benign histology and the presence of anti-Hu antibodies could be related to the positive oncological prognosis and to the slow clinical course mimicking a degenerative ataxia.
AuthorsRoberto Fancellu, Elena Corsini, Giorgio Bernardi, Paolo Buzzo, Maria Luisa Ferrari, Eleonora Lamantea, Alberto Garaventa, Mauro Truini, Sandro Salvarani
JournalFunctional neurology (Funct Neurol) 2014 Oct-Dec Vol. 29 Issue 4 Pg. 277-80 ISSN: 1971-3274 [Electronic] Italy
PMID25764259 (Publication Type: Case Reports, Journal Article)
Chemical References
  • ELAV Proteins
Topics
  • Adult
  • Cerebellar Ataxia (immunology, pathology)
  • ELAV Proteins (immunology)
  • Female
  • Ganglioneuroma (immunology, pathology)
  • Humans
  • Magnetic Resonance Imaging
  • Mediastinal Neoplasms (immunology, pathology)
  • Paraneoplastic Cerebellar Degeneration (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: